Literature DB >> 16819965

Pseudomonas aeruginosa pyocyanin inactivates lung epithelial vacuolar ATPase-dependent cystic fibrosis transmembrane conductance regulator expression and localization.

Fansheng Kong1, Lisa Young, Yi Chen, Huimin Ran, Melanie Meyers, Patricia Joseph, You-Hee Cho, Daniel J Hassett, Gee W Lau.   

Abstract

Pseudomonas aeruginosa (PA) is a major pathogen causing morbidity and ultimately mortality in patients afflicted with cystic fibrosis (CF) lung disease. One important virulence factor, pyocyanin (PCN), is a blue, redox-active compound that is secreted in such copious amounts by PA in the CF lungs that it determines the colour of expectorated sputum. In this study, we discovered that physiological concentrations of PCN inactivate the airway epithelial vacuolar ATPase, resulting in reduced expression and trafficking of the cystic fibrosis transmembrane conductance regulator in cultured lung and primary nasal epithelial cells. Our study supports the notion that PCN contributes significantly to the pathogenesis of CF and other bronchiectasis patients infected by PA.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16819965     DOI: 10.1111/j.1462-5822.2006.00696.x

Source DB:  PubMed          Journal:  Cell Microbiol        ISSN: 1462-5814            Impact factor:   3.715


  22 in total

1.  Specific resistance to Pseudomonas aeruginosa infection in zebrafish is mediated by the cystic fibrosis transmembrane conductance regulator.

Authors:  Ryan T Phennicie; Matthew J Sullivan; John T Singer; Jeffrey A Yoder; Carol H Kim
Journal:  Infect Immun       Date:  2010-08-23       Impact factor: 3.441

Review 2.  Pyocyanin effects on respiratory epithelium: relevance in Pseudomonas aeruginosa airway infections.

Authors:  Balázs Rada; Thomas L Leto
Journal:  Trends Microbiol       Date:  2012-11-07       Impact factor: 17.079

3.  Pseudomonas aeruginosa in cystic fibrosis patients with G551D-CFTR treated with ivacaftor.

Authors:  Sonya L Heltshe; Nicole Mayer-Hamblett; Jane L Burns; Umer Khan; Arthur Baines; Bonnie W Ramsey; Steven M Rowe
Journal:  Clin Infect Dis       Date:  2014-11-25       Impact factor: 9.079

4.  Glutaredoxin-1 attenuates S-glutathionylation of the death receptor fas and decreases resolution of Pseudomonas aeruginosa pneumonia.

Authors:  Vikas Anathy; Scott W Aesif; Sidra M Hoffman; Jenna L Bement; Amy S Guala; Karolyn G Lahue; Laurie W Leclair; Benjamin T Suratt; Carlyne D Cool; Matthew J Wargo; Yvonne M W Janssen-Heininger
Journal:  Am J Respir Crit Care Med       Date:  2014-02-15       Impact factor: 21.405

5.  Cif is negatively regulated by the TetR family repressor CifR.

Authors:  Daniel P MacEachran; Bruce A Stanton; George A O'Toole
Journal:  Infect Immun       Date:  2008-05-05       Impact factor: 3.441

6.  Redox-independent activation of NF-kappaB by Pseudomonas aeruginosa pyocyanin in a cystic fibrosis airway epithelial cell line.

Authors:  Christian Schwarzer; Zhu Fu; Horst Fischer; Terry E Machen
Journal:  J Biol Chem       Date:  2008-08-05       Impact factor: 5.157

Review 7.  Pseudomonas aeruginosa lipopolysaccharide: a major virulence factor, initiator of inflammation and target for effective immunity.

Authors:  Gerald B Pier
Journal:  Int J Med Microbiol       Date:  2007-04-27       Impact factor: 3.473

8.  Oxidative stress caused by pyocyanin impairs CFTR Cl(-) transport in human bronchial epithelial cells.

Authors:  Christian Schwarzer; Horst Fischer; Eun-Jin Kim; Katharine J Barber; Aaron D Mills; Mark J Kurth; Dieter C Gruenert; Jung H Suh; Terry E Machen; Beate Illek
Journal:  Free Radic Biol Med       Date:  2008-09-23       Impact factor: 7.376

9.  Redox warfare between airway epithelial cells and Pseudomonas: dual oxidase versus pyocyanin.

Authors:  Balázs Rada; Thomas L Leto
Journal:  Immunol Res       Date:  2009       Impact factor: 2.829

10.  The Pseudomonas aeruginosa secreted protein PA2934 decreases apical membrane expression of the cystic fibrosis transmembrane conductance regulator.

Authors:  Daniel P MacEachran; Siying Ye; Jennifer M Bomberger; Deborah A Hogan; Agnieszka Swiatecka-Urban; Bruce A Stanton; George A O'Toole
Journal:  Infect Immun       Date:  2007-05-14       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.